Cryolife Inc. - CRY- Profile

Cryolife, Inc.. The Group's principal activities are to develop and commercialize biomaterials, implantable medical devices, and preserve and distribute human tissues for cardiovascular and vascular transplant applications. The Group operates in two segments: Implantable Medical Devices and Human Tissue Preservation Services. The Implantable medical devices segment includes the sales of BioGlue and bioprosthetic devices, including stentless porcine heart valves and SynerGraft processed bovine vascular grafts. The Human Tissue Preservation Services segment includes the preservation of cardiac, vascular, and orthopaedic allograft tissues. The Group's products are marketed in Latin America, Europe, the Middle East, Canada, South America, Australia and Asia. Implantable Medical Devices accounted for 51% of 2006 revenues; Human Tissue Preservation Services, 49% and Others, nominal